German Biotech Stock News

XTRA:VNA
XTRA:VNAReal Estate

Assessing Vonovia (XTRA:VNA) Valuation After Mixed Signals In Its Latest Quarterly Earnings

Q1 earnings and shifting signals for Vonovia Vonovia (XTRA:VNA) has moved into focus after its first quarter 2026 earnings, where modest sales of €1,218.8 million contrasted with a sharp year-on-year drop in net income to €210.5 million. At the same time, management highlighted growth in Rental adjusted EBITDA, stronger Value-add EBITDA and progress on reducing leverage. This gives investors a mix of weaker headline profit and more resilient underlying operations to weigh. See our latest...
XTRA:IFX
XTRA:IFXSemiconductor

Infineon Expands AI Sensors And Enters Connected Senior Care Market

Infineon Technologies (XTRA:IFX) is acquiring the non-optical sensor business from ams OSRAM, expanding its sensor portfolio for AI and data center uses. The company is also partnering with the Health Impact Alliance to develop connectivity solutions for senior care within a new healthcare ecosystem. These developments have not been covered in recent Simply Wall St articles and may influence how investors view Infineon's future positioning. Infineon Technologies enters these deals with...
XTRA:EVK
XTRA:EVKChemicals

Evonik Industries (XTRA:EVK) Margin Improvement Tests Bullish Profitability Narrative

Evonik Industries (XTRA:EVK) closed FY 2025 with fourth quarter revenue of €3.4b and basic EPS of €0.04, while for the trailing twelve months revenue was €14.1b and basic EPS was €0.57, alongside net income of €265m. Over recent quarters, revenue has ranged from €3.4b to €3.8b and quarterly basic EPS has moved between a loss of €0.23 and a profit of €0.50, giving investors a clear view of how the earnings profile has shifted through the year. With net profit margins at 1.9% over the last...
XTRA:BEI
XTRA:BEIPersonal Products

Assessing Beiersdorf (XTRA:BEI) Valuation After Recent Share Price Weakness

Recent performance snapshot With no fresh company specific headlines to anchor sentiment, Beiersdorf (XTRA:BEI) has been trading on recent performance, including a last close of €72.34 and negative returns over the past year and past 3 months. See our latest analysis for Beiersdorf. The recent 2.5% 7 day share price return contrasts with a 30 day share price decline of 4.8% and a 1 year total shareholder return decline of 39.3%, pointing to fading momentum rather than a sustained recovery. If...
XTRA:SMHN
XTRA:SMHNSemiconductor

SUSS MicroTec (XTRA:SMHN) Margin Compression Challenges Bullish Expansion Narrative

SUSS MicroTec (XTRA:SMHN) has just posted its FY 2025 numbers, with Q4 revenue of €118.8 million and basic EPS of €0.51, while the trailing twelve months show revenue of €503.2 million and EPS of €2.59. Over recent periods the company has seen quarterly revenue move between €102.5 million and €151.4 million and quarterly EPS range from €0.48 to €0.85, giving investors a clear view of how top line and EPS have tracked together across the last six quarters. With the latest figures in hand, the...
XTRA:LHA
XTRA:LHAAirlines

Lufthansa (XTRA:LHA) Q1 Loss Challenges Bullish Margin Narratives

Deutsche Lufthansa (XTRA:LHA) kicked off Q1 2026 with revenue of €8.7b and a basic EPS loss of €0.55, alongside net income excluding extra items of a €665m loss, setting a mixed tone for the quarter. The company has seen quarterly revenue move from €8.1b in Q1 2025 to €11.2b in Q3 2025 and €10.1b in Q4 2025. Basic EPS ranged from a €0.74 loss in Q1 2025 to a €0.81 profit in Q3 2025 and €0.21 in Q4 2025, putting the latest quarterly loss into a wider earnings cycle that investors will weigh...
XTRA:HEN3
XTRA:HEN3Household Products

A Look At Henkel (XTRA:HEN3) Valuation After Q1 2026 Growth, Share Buyback And M&A Progress

Henkel KGaA (XTRA:HEN3) is back in focus after reporting 1.7% organic sales growth for Q1 2026, completing a €1b share buyback, and advancing acquisitions that are expected to add around €1.6b in annual sales. See our latest analysis for Henkel KGaA. At a share price of €64.58, Henkel’s stock has seen a 3.99% 7 day share price return but a 19.05% 90 day share price decline, with a 5 year total shareholder return of 22.06% decline, which may indicate fading momentum despite the recent Q1...
XTRA:SIE
XTRA:SIEIndustrials

A Look At Siemens (XTRA:SIE) Valuation After New AI Partnership With Xometry

Siemens (XTRA:SIE) is drawing fresh attention after announcing a partnership with Xometry that brings AI driven manufacturability and supply chain intelligence into Siemens Xcelerator, alongside an approximately $50 million minority investment. See our latest analysis for Siemens. Against this backdrop of AI driven partnerships and growing exposure to smart grid and digital twin markets, Siemens' 30 day share price return of 14.45% and 1 year total shareholder return of 26.40% indicate that...
XTRA:ENR
XTRA:ENRElectrical

A Look At Siemens Energy (XTRA:ENR) Valuation After Strong Multi Period Share Price Gains

Event context and recent stock performance Siemens Energy (XTRA:ENR) stock has drawn fresh attention after a recent move that left the shares with a 1 day return of about a 3% decline, following a relatively flat past week. Over the past month the stock shows a return of about 22%, while the past 3 months reflect roughly 19%. Year to date, the shares show around 47% total return, with about 147% over the past year. See our latest analysis for Siemens Energy. At a share price of €180.68,...
XTRA:SRT3
XTRA:SRT3Life Sciences

Is It Time To Reconsider Sartorius (XTRA:SRT3) After Its Recent Share Price Slide?

This article examines whether Sartorius is attractively priced or still demanding at today’s levels by walking through what the current share price might be implying about value. The stock last closed at €221.50, with returns of 2.0% over 7 days and 6.4% over 30 days, while year to date performance stands at a 10.6% decline and the 1 year return is a 2.5% decline. Over the past 3 and 5 years, shareholders have experienced declines of 35.7% and 45.2%. This provides important context for...
XTRA:DBK
XTRA:DBKCapital Markets

Is Deutsche Bank (XTRA:DBK) Still Attractively Priced After Mixed Recent Share Performance?

If you are wondering whether Deutsche Bank at €27.20 is still reasonably priced or already stretched, the key is to look closely at what the current valuation is really implying. The stock has moved 2.6% over the last week and 6.1% over the last month, while year to date it is down 19.0% and up 17.9% over the last year. Recent returns therefore give a mixed picture of risk and opportunity. Recent coverage has focused on how investors are reassessing large European banks and their capital...
XTRA:FME
XTRA:FMEHealthcare

A Look At Fresenius Medical Care (XTRA:FME) Valuation After Mixed Q1 2026 Results And €1b Share Buyback

Fresenius Medical Care (XTRA:FME) is back in focus after first quarter 2026 earnings showed mixed results, alongside confirmation of flat full year guidance and completion of a €1b share buyback representing about 8.5% of share capital. See our latest analysis for Fresenius Medical Care. Despite the 3.82% 1 day share price return taking the stock to €37.2, Fresenius Medical Care’s 30 day share price return of 4.88% and 1 year total shareholder return of 23.41% point to fading momentum...
XTRA:DHL
XTRA:DHLLogistics

Assessing DHL Group (XTRA:DHL) Valuation After Name Change Vote And Transformation Plan

Why Deutsche Post (XTRA:DHL) is back in focus after its shareholder vote Deutsche Post (XTRA:DHL) has moved back into the spotlight after shareholders backed a legal name change to DHL, a carve out of Post & Parcel Germany, and a broader transformation plan. See our latest analysis for Deutsche Post. The recent shareholder vote and the broader DHL rebranding sit against a mixed share price backdrop, with a 1-year total shareholder return of 31.72% contrasting with a modest 0.87% year to date...
XTRA:ZAL
XTRA:ZALSpecialty Retail

Is Zalando (XTRA:ZAL) Now Attractive After A 35% One-Year Share Price Slide?

Wondering whether Zalando at €20.28 is starting to look like value or still has more risk priced in? This article breaks down what the current share price implies. The stock has faced sustained pressure, with returns of a 3.6% decline over the last week, 1.1% decline over the last month, 17.8% decline year to date and 35.5% decline over the past year. This context helps explain how the market is currently thinking about its prospects. Recent coverage has focused on how Zalando is adjusting...
XTRA:BMW
XTRA:BMWAuto

BMW E Ink iX3 Flow Edition Puts Spotlight On Valuation Gap

BMW, listed as XTRA:BMW, unveiled the iX3 Flow Edition with E Ink Prism at the Beijing Auto Show 2026. The model is described as the first series ready integration of E Ink exterior technology on a production automobile. The E Ink based exterior allows customizable, digital patterns on the vehicle body rather than remaining a concept stage feature. At a share price of €81.4, XTRA:BMW sits against a mixed recent track record, with the stock up 5.0% over the past week and 12.9% over the past...
XTRA:CBK
XTRA:CBKBanks

UniCredit Tender Sparks Questions On Commerzbank Control And Valuation Gap

UniCredit has launched a tender offer to lift its ownership stake in Commerzbank above a key regulatory threshold. The move could give UniCredit greater influence over Commerzbank’s future focus and decision making. Commerzbank’s leadership has publicly opposed a full takeover, highlighting tension around control of the bank. Commerzbank (XTRA:CBK) trades at around €36.94, with the stock showing a 4.2% return over the past week and 17.3% over the past month. Over 1 year, the return stands...
XTRA:MBG
XTRA:MBGAuto

Weaker Q1 Earnings and US Tariff Risks Might Change The Case For Investing In Mercedes-Benz Group (XTRA:MBG)

In the first quarter of 2026, Mercedes-Benz Group AG reported sales of €25,497 million and net income of €1,418 million, both lower than a year earlier. At the same time, renewed US tariff threats on European cars have added policy uncertainty to Mercedes-Benz’s already pressured automotive earnings profile. Next, we’ll explore how weaker quarterly profitability amid renewed US tariff risks could influence Mercedes-Benz Group’s existing investment narrative. The latest GPUs need a type of...
XTRA:MRK
XTRA:MRKPharmaceuticals

A Look At Merck KGaA (XTRA:MRK) Valuation After Advancing Enpatoran To Global Phase 3 Lupus Trials

Merck KGaA (XTRA:MRK) has drawn fresh attention after dosing the first patient in its global Phase 3 ELOWEN-1 and ELOWEN-2 trials of enpatoran in lupus with active skin manifestations, marking a late stage pipeline milestone. See our latest analysis for Merck KGaA. The ELOWEN Phase 3 update and the recent Hybrid Drugs collaboration with Remepy come as Merck KGaA’s 7 day share price return of 5.08% and 1 day gain of 2.85% contrast with a 1 year total shareholder return decline of 4.23% and a 3...
XTRA:ELG
XTRA:ELGSemiconductor

A Look At Elmos Semiconductor (XTRA:ELG) Valuation After Raised 2026 Sales And Margin Guidance

Q1 2026 earnings and guidance change Elmos Semiconductor (XTRA:ELG) reported first quarter 2026 sales of €152.49 million and net income of €26.18 million, and then raised full year sales growth and EBIT margin guidance on continued high demand. See our latest analysis for Elmos Semiconductor. At a share price of €186.0, Elmos Semiconductor has seen strong momentum, with an 87.12% year to date share price return and a very large 1 year total shareholder return, although the 1 day share price...
XTRA:RWE
XTRA:RWERenewable Energy

Is It Too Late To Consider RWE (XTRA:RWE) After Its 85% One Year Rally?

Wondering whether RWE's share price still makes sense after a strong run, or if expectations have gone too far? This article focuses squarely on what the current price implies about value. RWE's stock closed at €59.42, with returns of 26.7% year to date and 85.0% over the last year, even though the last 7 days show a 2.0% decline and the last 30 days sit at 0.7%. Recent coverage has centered on RWE as a large European utility with significant exposure to renewable energy projects and ongoing...
XTRA:GIL
XTRA:GILMachinery

DMG MORI (XTRA:GIL) Margin Compression In Q1 2026 Challenges Bullish Earnings Narrative

DMG MORI (XTRA:GIL) has opened Q1 2026 with revenue of €472.1 million and basic EPS of €0.15, setting the tone against a trailing twelve month backdrop where revenue sits at about €2.1 billion and EPS is €0.99. Over recent quarters, revenue has ranged between €456.7 million and €689.5 million, while basic EPS has moved from €0.21 in Q1 2025 to €0.76 in Q4 2024 and €0.44 in Q4 2025, giving you a clear line of sight on how the top and bottom line have been tracking into this latest print. With...